Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03455374 · ClinicalTrials.gov registry record · NA
Diamondback in Peripheral Vascular Disease
A NA study, sponsored by Arkansas Heart Hospital.
- Terminated
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT03455374 is a NA study that was terminated before completion, run by Arkansas Heart Hospital. The registered enrollment target is 10 participants.
The verdict
NCT03455374, a NA study, was terminated before completion, sponsored by Arkansas Heart Hospital.
- TERMINATED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
This is a prospective, nonrandomized, single-arm study using CSI Orbital Atherectomy System in patients with PAD (total occlusions or significant stenosis). Patients will be enrolled if they have claudication and/or critical limb ischemia, and identifiable PAD disease with moderate to severe calcification on Computer Tomography Angiogram (PCA) or peripheral angiogram requiring percutaneous peripheral intervention (PPI).
Interventions
- DEVICE Treatment with CSI atherectomy device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2017-08-08 |
| Est. Completion | 2019-05-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03455374
The ClinicalTrials.gov registry entry for NCT03455374 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Arkansas Heart Hospital, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Treatment with CSI atherectomy device is the first listed.
NCT03455374 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03455374 about?
NCT03455374 is a clinical study titled "Diamondback in Peripheral Vascular Disease". This is a prospective, nonrandomized, single-arm study using CSI Orbital Atherectomy System in patients with PAD (total occlusions or significant stenosis). Patients will be enrolled if they have claudication and/or critical limb ischemia, and identifiable PAD disease with moderate to severe calcifi...
What is the current status of trial NCT03455374?
This trial is currently terminated. It is a NA study. The enrollment target is 10 participants. The study started on 2017-08-08. Estimated completion is 2019-05-13.
What interventions are being tested in trial NCT03455374?
The interventions under investigation include: Treatment with CSI atherectomy device (DEVICE).
Who is sponsoring clinical trial NCT03455374?
This trial is sponsored by Arkansas Heart Hospital, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.